Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.
Year: 1993
Type: article
Source: Molecular Pharmacology
Authors: B Poddevin, J F Riou, F Lavelle, Y Pommier
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2404444211
